Skip to main content

Advertisement

Log in

Aspergillus flavus malignant external otitis in a diabetic patient: case report and literature review

  • Review
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Purpose

Malignant external otitis is an aggressive and potentially life-threatening infection. This rare disorder is typically caused by Pseudomonas aeruginosa and affects almost exclusively elderly diabetic patients. However, fungal malignant external otitis have been identified, especially in immunocompromised hosts.

Methods

We report a rare case of invasive malignant external otitis caused by Aspergillus flavus in a diabetic patient without other underlying immunosuppression. A review of Aspergillus spp. malignant external otitis since voriconazole became the first line for invasive aspergillosis was performed.

Results

A 72-year-old man with diabetes mellitus developed invasive malignant external otitis with a vascular involvement. The patient was treated with empiric courses of antibiotics until a fungal infection was diagnosed. Proven Apsergillus infection was based on histopathological examination and isolation of A. flavus from culture of osteo-meningeal biopsies. Despite optimal antimicrobial therapy with voriconazole, the patient presented with cerebral infarction in the setting of an angioinvasive fungal infection leading to a fatal outcome. From a review of the literature, we found 39 previously published cases of proven Aspergillus spp. malignant external otitis treated with new triazoles.

Conclusion

Given our experience and the literature review, a fungal etiology should be considered early in the course of malignant external otitis unresponsive to a conventional broad spectrum antibiotic therapy, with the need for a tissue biopsy to confirm the diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Chandler JR. Malignant external otitis. Laryngoscope. 1968;78:1257–94.

    Article  CAS  Google Scholar 

  2. Hedayati MT, Pasqualotto AC, Warn PA, Bowyer P, Denning DW. Aspergillus flavus: human pathogen, allergen and mycotoxin producer. Microbiology. 2007;153:1677–92.

    Article  CAS  Google Scholar 

  3. Marzo SJ, Leonetti JP. Invasive fungal and bacterial infections of the temporal bone. Laryngoscope. 2003;113:1503–7.

    Article  Google Scholar 

  4. Amonoo-Kuofi K, Tostevin P, Knight JR. Aspergillus mastoiditis in a patient with systemic lupus erythematosus: a case report. Skull Base. 2005;15:109–12.

    Article  Google Scholar 

  5. Ling SS, Sader C. Fungal malignant otitis externa treated with hyperbaric oxygen. Int J Infect Dis. 2008;12:550–2.

    Article  Google Scholar 

  6. van Tol A, van Rijswijk J. Aspergillus mastoiditis, presenting with unexplained progressive otalgia, in an immunocompetent (older) patient. Eur Arch Otorhinolaryngol. 2009;266:1655–7.

    Article  Google Scholar 

  7. Parize P, Chandesris MO, Lanternier F, et al. Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review. Antimicrob Agents Chemother. 2009;53:1048–53.

    Article  CAS  Google Scholar 

  8. Soudry E, Hamzany Y, Preis M, et al. Malignant external otitis: analysis of severe cases. Otolaryngol Head Neck Surg. 2011;144:758–62.

    Article  Google Scholar 

  9. Bovo R, Benatti A, Ciorba A, et al. Pseudomonas and Aspergillus interaction in malignant external otitis: risk of treatment failure. Acta Otorhinolaringol Ital. 2012;32:416–9.

    CAS  Google Scholar 

  10. Tarazi AE, Al-Tawfiq A, Abdi RF. Fungal malignant otitis externa: pitfalls, diagnosis, and treatment. Otol Neurotol. 2012;33:769–73.

    Article  Google Scholar 

  11. Bhatt YM, Pahade N, Nair B. Aspergillus petrous apicitis associated with cerebral and peritubular abscesses in an immunocompetent man. J Laryngol Otol. 2013;127:404–7.

    Article  CAS  Google Scholar 

  12. Walton J, Coulson C. Fungal malignant otitis externa with facial nerve palsy: tissue biopsy aids diagnosis. Case Rep Otolaryngol. 2014;2014:192318.

    PubMed  PubMed Central  Google Scholar 

  13. Ho HC, Hsiao SH, Lee CY, Tsai CC. Treatment of refractory Aspergillus otomycosis with voriconazole: case series and review. J Laryngol Otol. 2014;128:547–51.

    Article  Google Scholar 

  14. Morgand M, Rammaert B, Poirée S, et al. Chronic invasive Aspergillus sinusitis and otitis with meningeal extension successfully treated with voriconazole. Antimicrob Agents Chemother. 2015;59:7857–61.

    Article  CAS  Google Scholar 

  15. Marchionni E, Parize P, Lefevre A, et al. Aspergillus spp. invasive external otitis: favourable outcome with a medical approach. Clin Microbiol Infect 2016;22:434–7.

  16. Lortholary O, Gangneux JP, Sitbon K, et al. Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007). Clin Microbiol Infect. 2011;17:1882–9.

    Article  CAS  Google Scholar 

  17. Hot A, Maunoury C, Poiree S, et al. Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections. Clin Microbiol Infect. 2011;17:409–17.

    Article  CAS  Google Scholar 

  18. Balajee SA, Borman AM, Brandt ME, et al. Sequence-based identification of Aspergillus, Fusarium and Mucorales species in the clinical mycology laboratory: where are we and where should we go from here ? J Clin Microbiol. 2009;47:877–84.

    Article  CAS  Google Scholar 

  19. Samson RA, Hong SB, Peterson SW, Frisvad JC, Varga J. Polyphasic taxonomy of Aspergillus section Fumigati and its teleomorph Neosartorya. Stud Mycol. 2007;59:1–47.

    Article  Google Scholar 

  20. Pasqualotto AC. Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus. Med Mycol 2009;47:S261–70.

  21. Delsing CE, Becker KL, Simon A, et al. Th17 cytokine deficiency in patients with Aspergillus skull base osteomyelitis. BMC Infect Dis. 2015;15:140.

    Article  Google Scholar 

  22. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327–60.

    Article  CAS  Google Scholar 

  23. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Eng J Med. 2002;347:408–15.

    Article  CAS  Google Scholar 

  24. Chen D, Lalwani AK, House JW, Choo D. Aspergillus mastoiditis in acquired immunodeficiency syndrome. Am J Otol. 1999;20:561–7.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maud Pichon.

Ethics declarations

Conflict of interest

Authors declare that there is no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pichon, M., Joly, V., Argy, N. et al. Aspergillus flavus malignant external otitis in a diabetic patient: case report and literature review. Infection 48, 193–203 (2020). https://doi.org/10.1007/s15010-020-01394-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-020-01394-8

Keywords

Navigation